Alnylam Pharmaceuticals
ALNY
#458
Rank
$52.61 B
Marketcap
$398.29
Share price
-0.28%
Change (1 day)
54.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company